Search results
Why AbbVie Stock Stumbled Today Despite the Earnings Beat
Motley Fool via Yahoo Finance· 2 days agoThe company even upped its full-year profit outlook. But AbbVie stock fell all the same, closing...
Better Dividend Stock: AbbVie or Johnson & Johnson?
Motley Fool via Yahoo Finance· 21 hours agoThe Motley Fool has positions in and recommends Abbott Laboratories. The Motley Fool recommends Johnson & Johnson. The Motley Fool has a disclosure...
AbbVie earnings beat by $0.04, revenue topped estimates By Investing.com
Investing.com· 3 days agoAbbVie earnings beat by $0.04, revenue topped estimates
Abbvie Inc (ABBV) Shares Up Despite Recent Market Volatility – News Heater
NewsHeater· 7 days agoThe stock price of Abbvie Inc (NYSE: ABBV) has surged by 1.06 when compared to previous closing price of 164.66, but ...
AbbVie (ABBV) Beats Q1 Earnings and Revenue Estimates
Zacks via Yahoo Finance· 3 days agoAbbVie (ABBV) delivered earnings and revenue surprises of 2.21% and 2.65%, respectively, for the...
Buying the Dip in These 3 Undervalued Dividend Stocks
Motley Fool via Yahoo Finance· 7 days ago*Stock prices used were end-of-day prices of April 18, 2024. The video was published on April 19,...
Gear Up for AbbVie (ABBV) Q1 Earnings: Wall Street Estimates for Key Metrics
Zacks· 6 days agoAhead of a company's earnings disclosure, it is crucial to give due consideration to changes in earnings estimates. Numerous empirical studies consistently demonstrate a strong relationship ...
AbbVie (ABBV) Reports Q1 Earnings: What Key Metrics Have to Say
Zacks via Yahoo Finance· 3 days agoWhile the top- and bottom-line numbers for AbbVie (ABBV) give a sense of how the business performed...
3 Dividend Stocks to Buy and Hold for the Next Decade
Motley Fool via Yahoo Finance· 2 days agoI think the sell-off is overdone, though, with shares now trading at a forward price-to-earnings...
AbbVie Q1 Preview: Skyrizi and Rinvoq’s launches could help Q1 (NYSE:ABBV)
Seeking Alpha· 4 days agoAbbVie (ABBV) is set to report Q1 earnings results on April 26th. Analysts expect a profit of $2.26...